Ketogenic Diet vs Further Antiseizure Medication in Infants with Drug-Resistant Epilepsy: What the KIWE Trial Adds to Clinical Practice

The KIWE randomised trial (Lancet Neurol 2023) found no superiority of a classic ketogenic diet over an additional antiseizure medication for seizure frequency in infants (1–24 months) with drug‑resistant epilepsy; tolerability and safety profiles were similar, supporting the diet as a viable treatment option.
Culturally Adapted Dementia Caregiver Support in Vietnam: New Evidence from the REACH VN Clinical Trial

Culturally Adapted Dementia Caregiver Support in Vietnam: New Evidence from the REACH VN Clinical Trial

A culturally adapted, multicomponent caregiver intervention (REACH VN) reduced psychological distress and stress among Vietnamese dementia caregivers at 3 months, though most benefits were not sustained at 6 months, highlighting both promise and challenges for scalable dementia care support in low-resource settings.